Corporate ActionMay 21, 2026, 06:07 AM
Nanobiotix Launches €75M Global Follow-On Offering
AI Summary
Nanobiotix S.A. announced the launch of a global follow-on offering aiming to raise approximately €75 million, or $87 million. The offering comprises a U.S. public offering of American Depositary Shares (ADSs) and an International offering of Ordinary Shares and pre-funded warrants (PFW). The company intends to use the net proceeds primarily to advance its Nanoprimer and other platforms (50-60%), for general corporate purposes (30-40%), and to support the development of JNJ-1900 (less than 10%).
Key Highlights
- Nanobiotix launched a global follow-on offering to raise approximately €75 million ($87 million).
- The offering includes a U.S. public offering of ADSs and an International offering of Ordinary Shares and pre-funded warrants (PFW).
- Underwriters have a 30-day option to purchase up to 15% additional ADSs.
- Securities will be issued without preferential subscription rights for existing shareholders.
- Less than 10% of net proceeds will support JNJ-1900 development.
- 50-60% of net proceeds will advance Nanoprimer and other platforms.
- 30-40% of net proceeds are allocated for general corporate purposes.
- The offering price for Ordinary Shares will be at least the 3-day Euronext VWAP, with a maximum 15% discount.
Price Impact
More from NBTX